|
tbar.gif
Click
here to
submit entries
|
|
|
Bristol-Myers
Selling ConvaTec Unit for $4.1B
|
May
2, 2008--Bristol-Myers
Squibb is planning to sell its ConvaTec wound-therapy unit to Nordic
Capital Fund VII for $4.1 billion. Bristol-Myers said the sale will yield
the additional financial resources needed as it tries to shift its focus more
toward biotechnology. AP/Forbes.com
|
|
|
Genstruct: Patience, Persistence, and Payoff
By John Russell |
|
Finding the right business model for systems biology (SB) technology providers has been challenging — that’s hardly a new theme in biotech.
Click
here
|
|
|
